Kyle LaHucik has been hired by Endpoints News as an associate editor covering the money, people, science and startups behind the drug development industry.
He was previously a staff writer at Fierce Biotech.
LaHucik previously reported on venture capital- and private equity-backed tech, digital health and SaaS companies for Mergermarket. He has also covered the rise of SPACs, a burgeoning teletherapy space and other COVID-accelerated trends within tech.
Through various internships, LaHucik has previously reported on the Big Three automakers for Bloomberg’s Detroit bureau, profiled the University of Missouri’s first Nobel Laureate for the Columbia Missourian, covered privacy regulation for Bloomberg Industry Group, wrote Missouri Business Alert’s daily newsletter and assisted reporters in MLex’s Brussels newsroom.
He graduated from the University of Missouri in May 2019 with a bachelor’s degree in journalism and minors in English creative writing and architectural studies.
